Evolution of the Average Target: Enovix Corporation

Evolution of the Target Price: Enovix Corporation

Changes in Analyst Recommendations: Enovix Corporation

0dfb419a417095c485ba1e368b.ORH45XOh09m9dfMuVa8cNoxRxidZxutVPDJd0bKvB_M.CmadojzUo7PMTKtfCsF2Re0h9GM8tNo_dwY34erEUIBXZJTVNtCB6fkUog~948b0e82bd90abe8f5a44c16532ebfa0
08-18 Top Midday Decliners MT
08-13 B. Riley Adjusts Price Target on Enovix to $9 From $10, Maintains Buy Rating MT
05-14 Oppenheimer Adjusts Price Target on Enovix to $21 From $24, Maintains Outperform Rating MT
05-06 JPMorgan Downgrades Enovix to Underweight MT
03-12 BofA Securities Initiates Enovix at Neutral With $6 Price Target MT
03-02 B. Riley Adjusts Enovix Price Target to $10 From $17, Maintains Buy Rating MT
24/07/25 JPMorgan Downgrades Enovix to Neutral From Overweight, Hikes Price Target to $12 From $9 MT
10/07/25 B. Riley Adjusts Price Target on Enovix to $17 From $12, Maintains Buy Rating MT
29/04/25 B. Riley Cuts Price Target on Enovix to $12 From $17, Keeps Buy Rating MT
31/10/24 Janney Downgrades Enovix to Neutral From Buy MT
26/08/24 Enovix to See Self-Funded Growth With Fab 2 Expansion Despite Rising Power Demands, Oppenheimer Says MT
30/07/24 B. Riley Adjusts Price Target on Enovix to $17 From $16, Maintains Buy Rating MT
22/07/24 Benchmark Starts Enovix With Buy Rating, $25 Price Target MT
30/04/24 B. Riley Lowers Price Target on Enovix to $16 From $18, Keeps Buy Rating MT
08/11/23 Cantor Fitzgerald Adjusts Enovix's Price Target to $30 From $28, Maintains Overweight Rating MT
06/11/23 B. Riley Lowers Enovix's Price Target to $18 From $25, Keeps Buy Rating MT
21/07/23 TD Cowen Downgrades Enovix to Market Perform From Outperform MT
20/07/23 B. Riley Raises Enovix's Price Target to $25 From $18, Keeps Buy Rating MT
05/07/23 EF Hutton Assumes Enovix at Buy With $21 Price Target MT
27/04/23 EF Hutton Adjusts Enovix Price Target to $21 From $18, Maintains Buy Rating MT
23/02/23 Craig Hallum Lowers Enovix's Price Target to $15 From $23, Maintains Buy Rating MT
23/02/23 Piper Sandler Adjusts Price Target on Enovix to $25 From $22.50, Maintains Overweight Rating MT
27/01/23 EF Hutton Adjusts Enovix's Price Target to $18 From $23, Maintains Buy Rating MT
26/01/23 JPMorgan Adjusts Enovix's Price Target to $16 From $28, Keeps Overweight Rating MT
23/01/23 Piper Sandler Adjusts Enovix Price Target to $22.50 From $26.50, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+241.87%
+36.67%
+30.81%
+62.1%
+54.52%
+23.2%
+38.85%
+25.69%
+48.28%
Average +62.44%
Weighted average by Cap. +39.76%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
3.320USD
Average target price
11.35USD
Spread / Average Target
+241.87%
High Price Target
21.00USD
Spread / Highest target
+532.53%
Low Price Target
5.000USD
Spread / Lowest Target
+50.60%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. ENVX Stock
  4. Consensus Enovix Corporation
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!